FDA accepts applications for nivolumab four week dosing schedule across all approved indications
admin 14th August 2017 Uncategorised 0European Society for Medical Oncology News
More: FDA accepts applications for nivolumab four week dosing schedule across all approved indications
Source: MDlinx